EMJ Oncology 8 [Supplement 1] . 2020

In this issue

Up to 80% of patients with cancer are affected by chemotherapy-induced nausea and vomiting (CINV) if the appropriate preventive healthcare is not given1. Affecting patients’ quality of life and chemotherapy compliance, this distressing side effect is considered by many patients to be among the most burdensome of the disease.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.